A detailed history of Pro Share Advisors LLC transactions in Alector, Inc. stock. As of the latest transaction made, Pro Share Advisors LLC holds 21,000 shares of ALEC stock, worth $53,970. This represents 0.0% of its overall portfolio holdings.

Number of Shares
21,000
Previous 15,639 34.28%
Holding current value
$53,970
Previous $71,000 38.03%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$4.34 - $6.58 $23,266 - $35,275
5,361 Added 34.28%
21,000 $98,000
Q2 2024

Aug 13, 2024

SELL
$4.19 - $6.23 $17,053 - $25,356
-4,070 Reduced 20.65%
15,639 $71,000
Q1 2024

May 08, 2024

BUY
$5.69 - $8.08 $21,775 - $30,922
3,827 Added 24.1%
19,709 $118,000
Q4 2023

Feb 14, 2024

BUY
$3.77 - $8.39 $8,135 - $18,105
2,158 Added 15.72%
15,882 $126,000
Q3 2023

Nov 13, 2023

BUY
$5.2 - $8.77 $390 - $657
75 Added 0.55%
13,724 $88,000
Q2 2023

Aug 10, 2023

BUY
$5.86 - $7.93 $3,363 - $4,551
574 Added 4.39%
13,649 $82,000
Q1 2023

May 11, 2023

SELL
$5.85 - $9.84 $10,336 - $17,387
-1,767 Reduced 11.91%
13,075 $80,000
Q4 2022

Feb 02, 2023

BUY
$6.88 - $9.55 $7,155 - $9,932
1,040 Added 7.54%
14,842 $136,000
Q3 2022

Nov 04, 2022

BUY
$8.19 - $13.2 $3,308 - $5,332
404 Added 3.02%
13,802 $130,000
Q2 2022

Aug 01, 2022

SELL
$7.65 - $14.24 $46,282 - $86,152
-6,050 Reduced 31.11%
13,398 $136,000
Q1 2022

May 10, 2022

SELL
$13.02 - $20.78 $61,962 - $98,892
-4,759 Reduced 19.66%
19,448 $277,000
Q4 2021

Feb 08, 2022

SELL
$19.35 - $25.54 $10,777 - $14,225
-557 Reduced 2.25%
24,207 $500,000
Q3 2021

Nov 12, 2021

SELL
$21.65 - $39.49 $97,706 - $178,218
-4,513 Reduced 15.41%
24,764 $565,000
Q2 2021

Aug 13, 2021

BUY
$15.5 - $22.48 $91,388 - $132,542
5,896 Added 25.22%
29,277 $610,000
Q1 2021

May 14, 2021

BUY
$14.84 - $22.23 $13,890 - $20,807
936 Added 4.17%
23,381 $471,000
Q4 2020

Feb 09, 2021

BUY
$9.4 - $16.7 $37,562 - $66,733
3,996 Added 21.66%
22,445 $340,000
Q3 2020

Nov 13, 2020

SELL
$10.54 - $24.96 $4,953 - $11,731
-470 Reduced 2.48%
18,449 $194,000
Q2 2020

Aug 03, 2020

BUY
$21.87 - $33.11 $170,411 - $257,993
7,792 Added 70.03%
18,919 $462,000
Q1 2020

May 15, 2020

SELL
$16.25 - $35.28 $128,131 - $278,182
-7,885 Reduced 41.47%
11,127 $268,000
Q4 2019

Feb 12, 2020

BUY
$14.17 - $20.3 $269,400 - $385,943
19,012 New
19,012 $328,000

Others Institutions Holding ALEC

About Alector, Inc.


  • Ticker ALEC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 82,563,904
  • Market Cap $212M
  • Description
  • Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...
More about ALEC
Track This Portfolio

Track Pro Share Advisors LLC Portfolio

Follow Pro Share Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.